Jesús
San Miguel Izquierdo
Consultor Investigador
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublications en collaboration avec des chercheurs de Hospital Universitari de Bellvitge (2)
2020
-
Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality
Blood Cancer Journal, Vol. 10, Núm. 10
2015
-
Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: Results of the randomized AZABACHE Spanish trial
Haematologica, Vol. 100, Núm. 9, pp. 1207-1213